Nectar Lifesciences has informed that pursuant to Regulations 29, 30, 33 and other applicable Regulations of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, a meeting of the Board of Directors of the company will be held on Thursday, August 14, 2025 to consider and approve, amongst other items, the Unaudited Financial Results for the quarter ended on June 30, 2025 and matters related thereto.
The above information is a part of company’s filings submitted to BSE.
